The impact of immortal time bias on the estimated mortality benefit of antifibrotic therapy in IPF

被引：0

作者：

Wilskow, Marit Bjorna ^{[1
]}

Diep, Phuong Phuong ^{[2
,3
]}

Hyldgaard, Charlotte ^{[4
]}

Carlson, Lisa ^{[5
]}

Kalafatis, Dimitrios ^{[5
]}

Pesonen, Ida ^{[5
]}

Skoeld, Magnus ^{[6
,7
]}

Shaker, Saher Burhan ^{[8
]}

Bendstrup, Elisabeth ^{[9
]}

Hoyer, Nils ^{[8
]}

Durheim, Michael Thomas ^{[2
,3
]}

机构：

[1] Nordland Hosp, Dept Resp Med, Bodo, Norway

[2] Oslo Univ Hosp, Dept Resp Med, Rikshosp, Oslo, Norway

[3] Univ Oslo, Inst Clin Med, Oslo, Norway

[4] Silkeborg Reg Hosp, Diag Ctr, Silkeborg, Denmark

[5] Karolinska Inst, Dept Med Solna, Resp Med Unit, Stockholm, Sweden

[6] Karolinska Univ Hosp, Dept Resp Med & Allergy, Stockholm, Sweden

[7] Karolinska Inst, Dept Med Solna, Stockholm, Sweden

[8] Herlev & Gentofte Hosp, Dept Resp Med, Copenhagen, Denmark

[9] Aarhus Univ, Ctr Rare Lung Dis, Dept Resp Dis & Allergy, Dept Clin Med,Ctr Rare Lung Dis, Aarhus, Denmark

来源：

EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷

关键词：

D O I：

10.1183/13993003.congress-2024.PA2433

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[1] An Eternal Dilemma: Exposing the Impact of Immortal Time Bias on Antifibrotic Effectiveness
Kyle, Andrew R.
Dempsey, Timothy M.
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (10) : 1383 - 1384
[2] Impact Of Immortal Time Bias On The Association Between Renal Replacement Therapy And Cardiogenic Shock Mortality
Mackenzie, Colin
Kyriakopoulos, Christos p.
Scott, Monte
Dranow, Elizabeth
Maneta, Eleni
Hamouche, Rana
Sheffield, Eric
Taleb, Iosif
Sinha, Shashank s.
Vallabhajosyul, Saraschandra
Fang, James
Drakos, Stavros
Hanff, Thomas
JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
[3] IPF-Mortality in Everyday Life with and without antifibrotic Therapy
Klein, Friederike
PNEUMOLOGIE, 2020, 74 (12): : 805 - 805
[4] Statins in Multiple Myeloma: Survival Benefit or Immortal Time Bias?
Suissa, Samy
Klil-Drori, Adi J.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (12) : 1377 - +
[5] An unjustified benefit: immortal time bias in the analysis of time-dependent events
Gleiss, Andreas
Oberbauer, Rainer
Heinze, Georg
TRANSPLANT INTERNATIONAL, 2018, 31 (02) : 125 - 130
[6] Statins in Multiple Myeloma: Survival Benefit or Immortal Time Bias? Reply
Sanfilippo, Kristen M.
Luo, Suhong
Gage, Brian F.
Carson, Kenneth R.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (12) : 1378 - +
[7] Sequential Therapy and Immortal Time Bias in Register Studies
Ambring, A.
Stierner, U.
Oden, A.
Bjorholt, I.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S164 - S164
[8] The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study
Zheng, Qiang
Otahal, Petr
Cox, Ingrid A. A.
de Graaff, Barbara
Campbell, Julie A. A.
Ahmad, Hasnat
Walters, E. Haydn
Palmer, Andrew J. J.
FRONTIERS IN MEDICINE, 2023, 10
[9] Inhaled steroids and mortality in COPD: bias from unaccounted immortal time
Suissa, S
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (03) : 391 - 395
[10] Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
Suissa, Samy
Suissa, Karine
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (01) : 105 - 109

← 1 2 3 4 5 →